CA Patent

CA2223154A1 — Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors

Assigned to GD Searle LLC · Expires 1996-12-05 · 29y expired

What this patent protects

This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to compounds of formula (I), compositions and methods for treating disorders mediated by cyclooxygenase-2 or 5-lipoxygenase such as inflammation.

USPTO Abstract

This invention is in the field of antiinflammatory pharmaceutical agents and specifically relates to compounds of formula (I), compositions and methods for treating disorders mediated by cyclooxygenase-2 or 5-lipoxygenase such as inflammation.

Drugs covered by this patent

Patent Metadata

Patent number
CA2223154A1
Jurisdiction
CA
Classification
—
Expires
1996-12-05
Drug substance claim
No
Drug product claim
No
Assignee
GD Searle LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.